Allmed Ebitda from 2010 to 2024

002950 Stock   9.10  0.47  4.91%   
Allmed Medical's EBITDA is increasing over the years with slightly volatile fluctuation. EBITDA is expected to dwindle to about 779.2 M. From 2010 to 2024 Allmed Medical EBITDA quarterly data regression line had arithmetic mean of  572,739,913 and r-squared of  0.38. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
820.6 M
Current Value
779.2 M
Quarterly Volatility
301.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Allmed Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Allmed Medical's main balance sheet or income statement drivers, such as Tax Provision of 84.1 M, Interest Income of 2.5 M or Interest Expense of 24.1 M, as well as many indicators such as . Allmed financial statements analysis is a perfect complement when working with Allmed Medical Valuation or Volatility modules.
  
This module can also supplement various Allmed Medical Technical models . Check out the analysis of Allmed Medical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Allmed Stock

Allmed Medical financial ratios help investors to determine whether Allmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allmed with respect to the benefits of owning Allmed Medical security.